Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in Type IIb hyperlipoproteinemia
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 30 (6) , 610-615
- https://doi.org/10.1016/0026-0495(81)90141-4
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effect of colestipol and clofibrate on plasma lipid and lipoproteins in Type IIa hyperlipoproteinemiaMetabolism, 1981
- Long-term trial with colestipol plus clofibrate in familial hypercholesterolemiaAtherosclerosis, 1978
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Pharmacokinetics of clofibrate in familial hypercholesterolemiaAtherosclerosis, 1977
- Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patientsAtherosclerosis, 1976
- Drug treatment of hyperlipidemiaThe American Journal of Medicine, 1976
- Differences among Hyperlipoproteinaemic Subjects in the Response of Lipoprotein Lipids to Resin TherapyEuropean Journal of Clinical Investigation, 1975
- Metabolic relationships among the plasma lipoproteinsJournal of Clinical Investigation, 1972
- Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in ManCirculation, 1969
- Treatment of hyperlipidemiasThe American Journal of Medicine, 1968